Loading...

Michael Kelner

TitleProfessor
InstitutionUniversity of California San Diego
DepartmentPathology
Address9300 Campus Point Drive #7721
La Jolla CA 92037
Phone858-657-5731
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Halogenated Alkenes and Microsomal GSH-transferases
    NIH/NIEHS R01ES013687Aug 8, 2006 - Apr 30, 2012
    Role: Principal Investigator
    ALTERATION OF ERCC GENE EXPRESSION IN VITRO AND IN VIVO
    NIH/NIA R01AG013153Aug 1, 1996 - Jul 31, 2000
    Role: Principal Investigator
    Coordinated Regulation of Antioxidant Enzymes
    NIH/NCI R01CA052310Apr 1, 1992 - Jun 30, 2006
    Role: Principal Investigator
    GENETIC INSIGHT INTO OXIDATIVE DAMAGE
    NIH/NIA R01AG010746Jan 15, 1992 - Dec 31, 1995
    Role: Principal Investigator
    GPX1 ENZYME REGULATION BY OXIDATIVE XENOBIOTICS
    NIH/NIEHS R01ES004989Jul 1, 1990 - Nov 30, 2004
    Role: Principal Investigator
    INHIBITION OF PARAQUAT OXYGEN-MEDIATED TOXICITY
    NIH/NIEHS K08ES000142Jul 1, 1985 - Jan 31, 1989
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bräutigam L, Zhang J, Dreij K, Spahiu L, Holmgren A, Abe H, Tew KD, Townsend DM, Kelner M, Morgenstern R, Johansson K. MGST1, a GSH transferase/peroxidase essential for development and hematopoietic stem cell differentiation. Redox Biol. 2018 Apr 16; 17:171-179. PMID: 29702404.
      View in: PubMed
    2. Staake MD, Kashinatham A, McMorris TC, Estes LA, Kelner M. Hydroxyurea derivatives of irofulven with improved antitumor efficacy. Bioorg Med Chem Lett. 2016 Apr 01; 26(7):1836-8. PMID: 26922141.
      View in: PubMed
    3. Kelner M, Diccianni MB, Yu AL, Rutherford MR, Estes LA, Morgenstern R. Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue. Free Radic Biol Med. 2014 Apr; 69:167-71. PMID: 24486338; PMCID: PMC4010302.
    4. Li K, Ku G, Yan M, Broome HE, Kelner M, Wang HY. A rare and unique case of aggressive IgE-? plasma cell myeloma in a 28-year-old woman presented initially as an orbital mass. Hum Pathol. 2012 Dec; 43(12):2376-84. PMID: 23084304.
      View in: PubMed
    5. McMorris TC, Chimmani R, Alisala K, Staake MD, Banda G, Kelner M. Structure-activity studies of urea, carbamate, and sulfonamide derivatives of acylfulvene. J Med Chem. 2010 Feb 11; 53(3):1109-16. PMID: 20067264.
      View in: PubMed
    6. Stadalman KA, Kelner M, Box K, Dominguez A, Rigby JF. Stability of levothyroxine sodium 0.4 microg/mL in 0.9% sodium chloride injection. Prog Transplant. 2009 Dec; 19(4):354-6; quiz 357. PMID: 20050459.
      View in: PubMed
    7. Vohra R, Kelner M, Clark RF. Preparation of crotaline F-ab antivenom (CroFab) with automated mixing methods: in vitro observations. Clin Toxicol (Phila). 2009 Jan; 47(1):69-71. PMID: 19153853.
      View in: PubMed
    8. Vohra R, Clark R, Kelner M. CroFab reconstitution in various media: an in vitro solubility study. Clin Toxicol (Phila). 2008 Nov; 46(9):808-10. PMID: 18821147.
      View in: PubMed
    9. Kelner M, McMorris TC, Rojas RJ, Estes LA, Suthipinijtham P. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model. Cancer Chemother Pharmacol. 2008 Dec; 63(1):19-26. PMID: 18305940.
      View in: PubMed
    10. Kelner M, McMorris TC, Rojas RJ, Estes LA, Suthipinijtham P. Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. Invest New Drugs. 2008 Oct; 26(5):407-15. PMID: 18227973.
      View in: PubMed
    11. Nguyen N, Bonzo JA, Chen S, Chouinard S, Kelner M, Hardiman G, Bélanger A, Tukey RH. Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease. J Biol Chem. 2008 Mar 21; 283(12):7901-11. PMID: 18180294.
      View in: PubMed
    12. McMorris TC, Chimmani R, Gurram M, Staake MD, Kelner M. Synthesis and antitumor activity of amine analogs of irofulven. Bioorg Med Chem Lett. 2007 Dec 15; 17(24):6770-2. PMID: 17977722.
      View in: PubMed
    13. Roboz GJ, Giles FJ, Ritchie EK, Allen-Bard S, Curcio TJ, Wilkes MA, Park SL, Kantarjian HM, Faderl S, Ravandi F, Kelner M, Feldman EJ. Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia. J Clin Oncol. 2007 Jan 01; 25(1):10-5. PMID: 17146106.
      View in: PubMed
    14. Kelner M, Bagnell RD, Morgenstern R. Structural organization of the murine microsomal glutathione S-transferase gene (MGST1) from the 129/SvJ strain: identification of the promoter region and a comprehensive examination of tissue expression. Biochim Biophys Acta. 2004 May 25; 1678(2-3):163-9. PMID: 15157743.
      View in: PubMed
    15. McMorris TC, Staake MD, Kelner M. Synthesis and biological activity of enantiomers of antitumor irofulven. J Org Chem. 2004 Feb 06; 69(3):619-23. PMID: 14750783.
      View in: PubMed
    16. McMorris TC, Cong Q, Kelner M. Structure-activity relationship studies of illudins: analogues possessing a spiro-cyclobutane ring. J Org Chem. 2003 Dec 12; 68(25):9648-53. PMID: 14656090.
      View in: PubMed
    17. Ekström L, Lyrenäs L, Jakobsson PJ, Morgenstern R, Kelner M. Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Sp1 and Sp3. Biochim Biophys Acta. 2003 Jun 19; 1627(2-3):79-84. PMID: 12818425.
      View in: PubMed
    18. McMorris TC, Moon SS, Kelner M. Reaction of irofulven with zinc and acid. J Nat Prod. 2003 Feb; 66(2):310-2. PMID: 12608875.
      View in: PubMed
    19. Jaspers NG, Raams A, Kelner M, Ng JM, Yamashita YM, Takeda S, McMorris TC, Hoeijmakers JH. Anti-tumour compounds illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways. DNA Repair (Amst). 2002 Dec 05; 1(12):1027-38. PMID: 12531012.
      View in: PubMed
    20. McMorris TC, Kashinatham A, Lira R, Rundgren H, Gantzel PK, Kelner M, Dawe R. Sesquiterpenes from Omphalotus illudens. Phytochemistry. 2002 Oct; 61(4):395-8. PMID: 12377232.
      View in: PubMed
    21. Kelner M, McMorris TC, Rojas RJ, Trani NA, Velasco TR, Estes LA, Suthipinijtham P. Enhanced antitumor activity of irofulven in combination with antimitotic agents. Invest New Drugs. 2002 Aug; 20(3):271-9. PMID: 12201490.
      View in: PubMed
    22. Kelner M, McMorris TC, Rojas RJ, Trani NA, Estes L. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C. Cancer Chemother Pharmacol. 2002 May; 49(5):412-8. PMID: 11976836.
      View in: PubMed
    23. Kelner M, Bagnell RD, Montoya MA, Lanham KA. Structural organization of the human gastrointestinal glutathione peroxidase (GPX2) promoter and 3'-nontranscribed region: transcriptional response to exogenous redox agents. Gene. 2000 May 02; 248(1-2):109-16. PMID: 10806356.
      View in: PubMed
    24. Kelner M, Bagnell RD, Montoya MA, Estes LA, Forsberg L, Morgenstern R. Structural organization of the microsomal glutathione S-transferase gene (MGST1) on chromosome 12p13.1-13.2. Identification of the correct promoter region and demonstration of transcriptional regulation in response to oxidative stress. J Biol Chem. 2000 Apr 28; 275(17):13000-6. PMID: 10777602.
      View in: PubMed
    25. Kelner M, Montoya MA. Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Biochem Biophys Res Commun. 2000 Mar 16; 269(2):366-8. PMID: 10708558.
      View in: PubMed
    26. Kelner M, McMorris TC, Estes LA, Oval MY, Rojas RJ, Lynn JR, Lanham KA, Samson KM. Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung carcinoma xenograft. Anticancer Drugs. 2000 Mar; 11(3):217-24. PMID: 10831281.
      View in: PubMed
    27. Kelner M, McMorris TC, Montoya MA, Estes L, Uglik SF, Rutherford M, Samson KM, Bagnell RD, Taetle R. Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines. Cancer Chemother Pharmacol. 1999; 44(3):235-40. PMID: 10453725.
      View in: PubMed
    28. Kelner M, Montoya MA. Structural organization of the human selenium-dependent phospholipid hydroperoxide glutathione peroxidase gene (GPX4): chromosomal localization to 19p13.3. Biochem Biophys Res Commun. 1998 Aug 10; 249(1):53-5. PMID: 9705830.
      View in: PubMed
    29. Kelner M, McMorris TC, Montoya MA, Estes L, Uglik SF, Rutherford M, Samson KM, Bagnell RD, Taetle R. Characterization of acylfulvene histiospecific toxicity in human tumor cell lines. Cancer Chemother Pharmacol. 1998; 41(3):237-42. PMID: 9443641.
      View in: PubMed
    30. McMorris TC, Yu J, Hu Y, Estes LA, Kelner M. Design and Synthesis of Antitumor Acylfulvenes. J Org Chem. 1997 May 02; 62(9):3015-3018. PMID: 11671671.
      View in: PubMed
    31. Kelner M, Estes L, Rutherford M, Uglik SF, Peitzke JA. Heterologous expression of carbonyl reductase: demonstration of prostaglandin 9-ketoreductase activity and paraquat resistance. Life Sci. 1997; 61(23):2317-22. PMID: 9408054.
      View in: PubMed